ETON PHARMACEUTICALS INC. - COMMON STOCK
16.96
12-February-25 14:52:26
15 minutes delayed
Stocks
-0.32
-1.82%
Today's range
16.75 - 17.17
ISIN
N/A
Source
NASDAQ
-
Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
03 Aug 2021 15:05:02 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
15 Jun 2021 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15 Jun 2021 09:37:52 By Nasdaq GlobeNewswire
-
28 May 2021 07:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Record Revenue and Earnings
13 May 2021 15:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04 May 2021 15:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16 Mar 2021 15:02:00 By Nasdaq GlobeNewswire
-
04 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16 Feb 2021 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 Jan 2021 07:00:01 By Nasdaq GlobeNewswire